432 filings
Page 4 of 22
8-K
ye42xg25y
26 Oct 21
Other Events
8:00am
8-K
1nkddgekww2v yinb
16 Aug 21
Vyant Bio Reports Second Quarter 2021 Results and Provides Strategic Business Updates
4:01pm
EFFECT
vmg3t5pp 0s4xrz7a
7 Jun 21
Notice of effectiveness
12:15am
POS AM
9c232e9kvopagi4qvb
18 May 21
Prospectus update (post-effective amendment)
12:00am
S-8
0qc5gfgwphglhx9echxq
18 May 21
Registration of securities for employees
12:00am
8-K
yb057bohhtahlpp2scdo
17 May 21
Vyant Bio Reports First Quarter 2021 Results and Provides Strategic Business Update
5:27pm
8-K
e3cso16smacj76aska
5 Apr 21
Report of Independent Registered Public Accounting Firm
5:12pm
8-K
l3eku
25 Mar 21
Cancer Genetics Announces Shareholder Approval of All Proposals in Connection with the Proposed Merger with StemoniX
9:17am
425
vjv4i89v9d em33
25 Mar 21
Business combination disclosure
9:15am
8-K
8uf5ichq99no
16 Mar 21
Other Events
7:02am
425
lhnzq t997vufctdw2
16 Mar 21
Business combination disclosure
7:00am
DEFR14A
2k1m yki9nwy3ux2txdm
26 Feb 21
Revised proxy
4:46pm
8-K
zeoq xgzp9vtiscv0b0
26 Feb 21
Entry into a Material Definitive Agreement
4:42pm
425
y999vm6lhif5b87a76k
26 Feb 21
Business combination disclosure
4:40pm
8-K
h9l8iicr3 7pjz
16 Feb 21
Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules
4:51pm
424B5
y8d92km9z
16 Feb 21
Prospectus supplement for primary offering
12:00am